Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

LON/SPI stock hub

LON/SPI has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/SPIis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

618.5M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/SPI

In the news

Latest news · LON/SPI

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E19.3

P25 12.9P50 16.9P75 23.5

Trailing P/E38.6

P25 15.9P50 22.9P75 35.8

ROE2.3

P25 -54.2P50 2.1P75 13.7

ROIC6.7

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/SPI market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

240

Groups with data

Currency

GBP

Showing 240 of 240 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	17,800
Employees Change	2,097%
Employees Change Percent	13.35
Enterprise value	GBX 1.9B
Exchange	London Stock Exchange
Financial currency	GBP
First seen	2026-05-10
Industry	Medical Care Facilities
Isin	GB00BNLPYF73
Last refreshed	2026-05-10
Market cap	GBX 618.5M
Price	GBX 154
Price currency	GBX
Rev Per Employee	88,752.81x
Sector	Healthcare
Sic	8060
Symbol	lon/SPI
Website	https://www.spirehealthcare.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.65%
EV Earnings	115.89x
EV/EBIT	13.05x
EV/EBITDA	7.24x
EV/FCF	11.46x
EV/Sales	1.2x
FCF yield	26.82%
Forward P/E	19.28x
P/B ratio	0.83x
P/E ratio	38.6x
P/S ratio	0.39x
PE Ratio10 Y	56.58x
PE Ratio3 Y	41.81x
PE Ratio5 Y	39.03x
PEG ratio	0.87x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	9.22%
EBITDA Margin	13.63%
FCF margin	10.5%
Gross margin	45.33%
Gross Profit	GBX 716.1M
Gross Profit Growth	2.49%
Gross Profit Growth Q	5.16%
Gross Profit Growth3 Y	2.96%
Gross Profit Growth5 Y	4.19%
Net Income	GBX 16.4M
Net Income Growth	-35.43%
Net Income Growth Q	-17.5%
Net Income Growth Years	0%
Net Income Growth3 Y	-16.63%
Net Income Growth5 Y	-5.27%
Pretax Margin	1.18%
Profit Margin	1.04%
Profit Per Employee	GBX 921
Profitable Years	4
ROA	3.86
Roa5y	3.29
ROCE	7.17
ROE	2.31
Roe5y	1.9
ROIC	6.65
Roic5y	5.45

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-6.24%
Cagr1y	-22.48%
Cagr3y	-12.61%
Cagr5y	-4.82%
Div CAGR10	-8.63%
Div CAGR3	44.22%
Div CAGR5	24.57%
EPS Growth	-35.48
EPS Growth Q	-19.29
EPS Growth Years	0
EPS Growth3 Y	-16.2
EPS Growth5 Y	-4.85
FCF Growth	31.25%
FCF Growth Q	50.08%
FCF Growth3 Y	9.46%
FCF Growth5 Y	8.16%
OCF Growth	2.76%
OCF Growth Q	0.24%
OCF Growth10 Y	4.25%
OCF Growth3 Y	1.61%
OCF Growth5 Y	5.34%
Revenue Growth	4.54x
Revenue Growth Q	4.6x
Revenue Growth Quarters	11x
Revenue Growth Years	5x
Revenue Growth3 Y	3.02x
Revenue Growth5 Y	4.35x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 0.67
Assets	GBX 2.4B
Cash	GBX 34.9M
Current Assets	GBX 221.5M
Current Liabilities	GBX 346.8M
Debt	GBX 1.3B
Debt EBITDA	GBX 5.01
Debt Equity	GBX 1.77
Debt FCF	GBX 7.93
Equity	GBX 743.7M
Interest Coverage	1.41
Liabilities	GBX 1.6B
Long Term Assets	GBX 2.2B
Long Term Liabilities	GBX 1.3B
Net Cash	GBX -1.3B
Net Cash By Market Cap	GBX -207
Net Debt EBITDA	GBX 5.95
Net Debt Equity	GBX 1.72
Net Debt FCF	GBX 7.72
Tangible Book Value	GBX 300.5M
Tangible Book Value Per Share	GBX 0.75
WACC	7.9

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.64
Inventory Turnover	18.61
Net Working Capital	GBX -49.5M
Quick ratio	0.39
Working Capital	GBX -125.3M
Working Capital Turnover	GBX -13.07

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.48%
Dividend Growth	-34.78%
Dividend Growth Years	2%
Dividend per share	GBX 0.02
Dividend Years	4
Dividend Yield	0.97%
Ex Div Date	2026-05-21
Last Dividend	GBX 0.02
Payout Frequency	Annual
Payout Ratio	56.1%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-47.48%
1Y total return	-22.47%
200-day SMA	200
3Y total return	-33.27%
50-day SMA	167.7
50-day SMA vs 200-day SMA	50under200
5Y total return	-21.88%
All Time High	411
All Time High Change	-62.43%
All Time High Date	2016-09-16
All Time Low	51.1
All Time Low Change	202.15%
All Time Low Date	2020-03-19
ATR	5.19
Beta	0.91
Beta1y	0.91
Beta2y	0.39
Ch YTD	-7.54
High	158
High52	256.5
High52 Date	2025-09-19
High52ch	-39.81%
Low	154.4
Low52	140.8
Low52 Date	2026-03-30
Low52ch	9.66%
Ma50ch	-7.92%
Price vs 200-day SMA	-22.8%
RSI	39.84
RSI Monthly	39.76
RSI Weekly	37.21
Sharpe ratio	-0.44x
Sortino ratio	-0.48
Total Return	2.45%
Tr YTD	-7.54
Tr1m	6.34%
Tr1w	-6.08%
Tr3m	-24.31%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX 145.6M
Operating Income Growth	1.75
Operating Income Growth Q	3.65
Operating Income Growth3 Y	3.06
Operating Income Growth5 Y	4.67
Operating margin	9.22

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	177,037,167%
Net Borrowing	-35,100,000
Shares Insiders	0.35%
Shares Institutions	42.05%
Shares Out	400,597,780
Shares Qo Q	-0.32%
Shares Yo Y	-1.48%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX 163.8M
Average Volume	1,356,833.15x
Bv Per Share	1.85
CAPEX	GBX -76.3M
Ch10y	-52.33
Ch1m	6.34
Ch1w	-6.08
Ch1y	-23.37
Ch3m	-24.31
Ch3y	-34.71
Ch5y	-23.56
Ch6m	-31.68
Change	-2.28%
Change From Open	-1.28
Close	158
Days Gap	-1.01
Depreciation Amortization	69,700,000
Dollar Volume	71,574,436
Earnings Date	2026-07-30
EBIT	GBX 145.6M
EBITDA	GBX 215.3M
EPS	GBX 0.04
F Score	7
FCF	GBX 165.9M
FCF EV Yield	8.73x
FCF Per Share	GBX 0.41
Financing CF	-164,500,000
Fiscal Year End	December
Founded	2,007
Goodwill	419,700,000
Graham Number	129.19
Graham Upside	-16.33
Income Tax	GBX 1.4M
Investing CF	-84,200,000
Is Primary Listing	1
Last Earnings Date	2026-03-05
Last Report Date	2025-12-31
Lynch Fair Value	GBX 20
Lynch Upside	-87.05
Ma150	192.6
Ma150ch	-19.83%
Ma20	160.5
Ma20ch	-3.78%
Net CF	-6,500,000
Next Earnings Date	2026-07-30
Open	156.4
P FCF Ratio	3.73
P OCF Ratio	2.55
Payment Date	2026-06-19
Position In Range	0
Ppne	1,692,100,000
Price Date	2026-05-08
Price EBITDA	GBX 2.87
Ptbv Ratio	2.06
Relative Volume	0.35x
Revenue	1,579,800,000x
SBC By Revenue	0.13x
Share Based Comp	2,100,000
Tax By Revenue	0.09x
Tax Rate	7.53%
Tr6m	-31.68%
Volume	463,565
Z Score	0.84

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/SPI dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.0%

$0.01 annual per share

Payout ratio

+56.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+24.6%

2 consecutive years of growth

Total shareholder yield

+2.4%

Next ex-dividend date: 2026-05-21

Performance

LON/SPI stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/SPI?

Insider, institutional, and short-interest positioning.

Institutional ownership

+42.1%

Share of float held by funds and institutions

Insider ownership

+0.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-1.5%

Negative means the company is buying back shares.

Technical

LON/SPI momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

39.8

Neutral momentum band

Price vs 200-day MA

-22.8%

50/200-day relationship not available

Beta (5Y)

0.91

Moves roughly with the market

Sharpe ratio

-0.44

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/SPI

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/SPI stock rating?

lon/SPI is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/SPI analysis?

The full report lives at /stocks/lon/SPI/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/SPI?

The latest report frames lon/SPI around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/SPI page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.